CompletedNot Applicable

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

United States220 participantsStarted 2022-04-21

Plain-language summary

The SWAF study will compare the performance of a smartwatch combined with Cardiologs Platform algorithm in the detection of Atrial Fibrillation and other arrhythmias with that measured on a manually read 12-lead ECG in subjects hospitalized for cardioversion or AF ablation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects over 18, able and willing to participate in the study * Subjects who are admitted to the hospital for a cardioversion or AF ablation procedure. * Subjects having read the patient information letter and provided his/her consent to participate in writing, by dating and signing the informed consent prior to any trial-related procedure being conducted Exclusion Criteria: * Subjects with paced rhythm or implanted electronic devices * Pregnant or breast-feeding subjects

What they're measuring

Evaluation of the performance of smartwatch ECG interpreted by Cardiologs Artificial Intelligence in detecting AF (Atrial Fibrillation or Flutter) as identified by the physician on the 12-lead ECG

Timeframe: Readings taken simultaneously right before and right after the cardioversion according to the monitoring protocol at the hospital

Trial details

NCT IDNCT05167058

SponsorCardiologs Technologies

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-01-20

View on ClinicalTrials.gov More Atrial Fibrillation trials